Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer - PubMed (original) (raw)
Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer
Liqun Zhang et al. Mol Ther. 2002 Mar.
Free article
Abstract
Gene therapy is founded on the concept that tissue-specific promoters can express heterologous genes for molecular imaging or therapeutic applications. The engineering of cell-specific enhancers to improve potency and the development of two-step transcriptional activation (TSTA) approaches have significantly improved the efficacy of transgene expression. Here we combine these technologies to create a robust, titratable, androgen-responsive system targeted to prostate cancer cells. Our "chimeric" TSTA system uses a duplicated variant of the prostate-specific antigen (PSA) gene enhancer to express GAL4 derivatives fused to one, two, or four VP16 activation domains. We targeted the resulting activators to cells with reporter templates bearing one, two, or five GAL4 binding sites upstream of firefly luciferase. We monitored activity via firefly luciferase assays in transfected cell extracts and in live nude mice using a cooled charge-coupled device (CCD) imaging system. In this system, we found that firefly luciferase expression in prostate cancer cells can be varied over an 800-fold range. We also found that a single plasmid bearing the optimized enhancer, GAL4-VP16 derivative, and reporter expressed firefly luciferase at 20-fold higher levels than the cytomegalovirus enhancer. We discuss the implications of this strategy and its application to molecular imaging and therapy.
Similar articles
- Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector.
Iyer M, Salazar FB, Lewis X, Zhang L, Carey M, Wu L, Gambhir SS. Iyer M, et al. Mol Ther. 2004 Sep;10(3):545-52. doi: 10.1016/j.ymthe.2004.06.118. Mol Ther. 2004. PMID: 15336654 - Two-step transcriptional amplification-lipid-based nanoparticles using PSMA or midkine promoter for suicide gene therapy in prostate cancer.
Hattori Y, Maitani Y. Hattori Y, et al. Cancer Sci. 2006 Aug;97(8):787-98. doi: 10.1111/j.1349-7006.2006.00243.x. Epub 2006 Jun 23. Cancer Sci. 2006. PMID: 16800821 Free PMC article. - Advanced two-step transcriptional amplification as a novel method for cancer-specific gene expression and imaging.
Watanabe M, Ueki H, Ochiai K, Huang P, Kobayashi Y, Nasu Y, Sasaki K, Kaku H, Kashiwakura Y, Kumon H. Watanabe M, et al. Oncol Rep. 2011 Oct;26(4):769-75. doi: 10.3892/or.2011.1371. Epub 2011 Jul 1. Oncol Rep. 2011. PMID: 21725614 - Ad5_-(PSE-BC)-(GAL4-(VP16)2)-(GAL4)5-sr39_tk.
Zhang H. Zhang H. 2008 Dec 15 [updated 2009 Jan 5]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Dec 15 [updated 2009 Jan 5]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641191 Free Books & Documents. Review. - _Ad5_-(PSE-BC)-(GAL4-(VP16)2)-(GAL4)5-Fluc.
Zhang H. Zhang H. 2008 Dec 5 [updated 2009 Jan 5]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Dec 5 [updated 2009 Jan 5]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641365 Free Books & Documents. Review.
Cited by
- Transcriptionally targeted gene therapy to detect and treat cancer.
Wu L, Johnson M, Sato M. Wu L, et al. Trends Mol Med. 2003 Oct;9(10):421-9. doi: 10.1016/j.molmed.2003.08.005. Trends Mol Med. 2003. PMID: 14557054 Free PMC article. Review. - Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy.
Iyer M, Salazar FB, Lewis X, Zhang L, Wu L, Carey M, Gambhir SS. Iyer M, et al. Transgenic Res. 2005 Feb;14(1):47-55. doi: 10.1007/s11248-004-2836-1. Transgenic Res. 2005. PMID: 15865048 - Cabozantinib and IL-27 combinatorial therapy for bone-metastatic prostate cancer.
Kumar S, Mulia GE, Figueiredo ML. Kumar S, et al. Front Mol Biosci. 2023 Sep 28;10:1259336. doi: 10.3389/fmolb.2023.1259336. eCollection 2023. Front Mol Biosci. 2023. PMID: 37842640 Free PMC article. - MicroPET imaging of Cre-loxP-mediated conditional activation of a herpes simplex virus type 1 thymidine kinase reporter gene.
Sundaresan G, Paulmurugan R, Berger F, Stiles B, Nagayama Y, Wu H, Gambhir SS. Sundaresan G, et al. Gene Ther. 2004 Apr;11(7):609-18. doi: 10.1038/sj.gt.3302194. Gene Ther. 2004. PMID: 14724687 Free PMC article. - Optical imaging for stem cell differentiation to neuronal lineage.
Hwang DW, Lee DS. Hwang DW, et al. Nucl Med Mol Imaging. 2012 Mar;46(1):1-9. doi: 10.1007/s13139-011-0122-8. Epub 2012 Jan 4. Nucl Med Mol Imaging. 2012. PMID: 24900026 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous